Electronic Issuance of Patents and Trademark Registrations Beginning in 2022
Patent
By: Mitch Gabanic On December 10th, the United States Patent and Trademark Office (USPTO) released its plan to modernize the…
Patent
Best Law Firms 2021 Recognizes Meunier Carlin & Curfman as a Top Firm
Copyright, Firm News, Litigation, Patent, Trademark
Intellectual Property firm Meunier Carlin & Curfman LLC (“MCC”) earned several recognitions in the latest U.S. News – Best Lawyers…
USPTO Announces Official Fee Increase
IP News, Patent
By: Shirlene Jackson-Beckford PhD The USPTO has announced an increase to its official fees which will come into effect on…
Patent Fees Increase January 16, 2018
IP News, Patent
Increased patent fees apply on January 16, 2018.
Glove Manufacturer Gets Burned in US Design Patent Damages Case
IP News, Patent
Heat-reflective materials in sportswear was contested in a design and utility patent case.
The U.S. Enters the International Design Frontier: The Ins and Outs of the Hague Agreement on Industrial Design
IP News, Patent
The U.S. became a member of the Geneva Act of the Hague Agreement in May 2015. U.S. applicants can now take advantage of a centralized procedure for global examination of design applications.
U.S. Patent Office Releases New Guidelines for Determining Subject Matter Eligibility
IP News, Patent
The USPTO recently released its 2014 Interim Guidance on Patent Subject Matter Eligibility.
Patent Office Awards Patent Term Adjustment Based on Delay Related to a Vacated Office Action
Firm News, Patent
Meunier Carlin & Curfman client Oncolytics Biotech Inc. of Calgary, Alberta, Canada, the assignee of US Patent No. 7,803,385 directed to a modified reovirus for the treatment of cancer, finally received a Certificate of Correction from the US Patent and Trademark Office (USPTO) showing 122 days of patent term adjustment, a patent term adjustment originally and repeatedly denied by the USPTO.
Legal Alert: The America Invents Act
Firm News, Patent
Chris Curfman discusses key provisions of the America Invents Act, recently signed into law.
Supreme Court Impacts Medical Diagnostics Patent Claims
IP News, Patent
The decision was handed down by the Supreme Court after a long wait on June 28, 2010. The Court upheld the Federal Circuit’s ruling that the claims at issue were not patentable subject matter. For proponents of reduced patent coverage for business method claims it was a Pyrrhic victory.